Skip to main content
. 2021 Sep 30;2021(9):CD010951. doi: 10.1002/14651858.CD010951.pub2

NCT03987256.

Study name Tennis elbow, randomized study: needling with and without platelet‐rich plasma after failure of up‐to‐date rehabilitation
Methods Single‐centre 2‐arm parallel randomised controlled trial
Participants Inclusion criteria
  • Lesion of the ECRB tendon on ultrasonography ([hypo‐echogenic area during rest or hypo‐echogenic area during active contraction, or compressibility of the tendon, or doppler signal] and [positive sonopalpation])

  • Failure of rehabilitation programme including shock wave therapy defined as the need for patient to undergo additional therapies


Exclusion criteria
  • Presence on ultrasound of an isolated lesion of the superficial epicondylar tendons as described above, with intact ECRB

  • Presence on ultrasound of any of the following: radiohumeral synovial material; interruption of the lateral collateral ligament; radial nerve entrapment (i.e. under the arcade of Frohse); osteochondral lesion; joint effusion. Note: calcic enthesophytes are not considered as an exclusion criterion

  • Clinical presence of cervicobrachialgia, or pain radiating into the hand

  • Glucocorticoid: oral intake or infiltration in the last 3 months

  • Proximal radius fracture history

  • Active inflammatory rheumatic disorder

  • Diabetes mellitus

  • Immunocompromized status

  • Allergy to local anaesthetic

  • Bleeding disorder or current anticoagulation therapy

  • Other clinically significant concomitant disease state (e.g. renal failure, hepatic dysfunction, cardiopulmonary significant insufficiency)

  • Known or suspected non‐compliance, drug or alcohol abuse

  • Inability to follow procedures of the study (e.g. due to language problems, psychological disorders, dementia of the participant)

  • Participation in another study with investigational drug within the 30 days preceding and during the present study

  • Previous enrolment into the current study

  • Enrolment of the investigator, his/her family members, employees, and other dependent persons

Interventions Needling with PRP vs needling with saline solution
Outcomes Primary outcome measure
Pain during isometric contraction of the ECRB [Time Frame: 3 months] Pain is evaluated on a 0 to 10 scale (0 = no pain) during isometric contraction manoeuvre of the ECRB

Secondary outcome measures
Pain during isometric contraction of the ECRB [Time Frame: ‐3, 0, 6, & 12 months] Pain is evaluated on a 0 to 10 scale (0 = no pain) during isometric contraction manoeuvre of the ECRB
Overall pain evaluation (mean of last 3 days) [Time Frame: ‐3, 0, 3, 6, & 12 months] Pain is evaluated on a 0 to 10 scale (0 = no pain)
SANE score (Single Assessment Numeric Evaluation) [Time Frame: ‐3, 0, 3, 6, & 12 months] Function is evaluated on a 0 to 100% scale (100 = good function)
PRTEE score (Patient‐Rated Tennis Elbow Evaluation) [Time Frame: ‐3, 0, 3, 6, & 12 months] Score going from 0 to 100 (0 = good outcome)
Strength on Jamar test (hand grip strength) [Time Frame: ‐3, 0, 3, 6, & 12 months] Grip strength measured in kg (higher strength = better outcome)
Proportion of patients cured with re‐education protocol [Time Frame: 0 months] Descriptive statistics: evaluation of the proportion of patients for which tendon needling is not necessary
Volume of PRP prepared [Time Frame: 0 months] Descriptive statistics: quantity of PRP prepared (in mL)
Volume of PRP (or saline solution) injected [Time Frame: 0 months] Descriptive statistics: quantity of PRP (or saline solution) injected (in mL)
Ultrasonographic aspect of the epicondylar tendon: hypo‐echogenic lesion [Time Frame: ‐3, 0, 3, & 6 months] The tri‐dimensional volume of the lesion is measured in mm³
Ultrasonographic aspect of the epicondylar tendon: Doppler [Time Frame: ‐3, 0, 3, & 6 months] The Doppler reaction will be evaluated on a subjective scale (none, mild, average, high, huge)
Ultrasonographic aspect of the epicondylar tendon: solution of continuity [Time Frame: ‐3, 0, 3, & 6 months] During active contraction of the ECRB, an eventual solution of continuity will be measured in mm
Ultrasonographic aspect of the epicondylar tendon: thickness [Time Frame: ‐3, 0, 3, & 6 months] The thickness of the common epitrochlear will be measured in mm
Ultrasonographic aspect of the epicondylar tendon: compressibility [Time Frame: ‐3, 0, 3, & 6 months] The presence or absence of compressibility of the common epitrochlear tendon (binary outcome)
Ultrasonography of the epicondylar tendon: sonopalpation [Time Frame: ‐3, 0, 3, & 6 months] Patient pain on sonopalpation will be evaluated on a 0 to 10 scale (0 = no pain)
Starting date 1 January 2020
Contact information Adrien Schwitzguébel,
Hôpital La Providence, Sports Medicine Neuchâtel, Switzerland
+4179 762 05 62
adrien.schwitzguebel@gmail.com
Notes Recruiting